Edition:
United Kingdom

Biostar Pharmaceuticals Inc (BSPM.OQ)

BSPM.OQ on NASDAQ Stock Exchange Capital Market

1.83USD
18 Sep 2018
Change (% chg)

$0.06 (+3.39%)
Prev Close
$1.77
Open
$1.83
Day's High
$1.83
Day's Low
$1.83
Volume
204
Avg. Vol
41,269
52-wk High
$5.96
52-wk Low
$1.18

Latest Key Developments (Source: Significant Developments)

Biostar Pharmaceuticals Says Says Ronghua Wang Agreed To Sell His 426,999 Shares Of Co In Private Sale To Waiping Liu At $1.57/Share
Friday, 6 Jul 2018 

July 6 (Reuters) - Biostar Pharmaceuticals Inc ::BIOSTAR PHARMACEUTICALS SAYS HAS COME TO ATTENTION OF CO THAT CHAIRMAN, CEO RONGHUA WANG ENTERED A CERTAIN SHARE PURCHASE AGREEMENT WITH WAIPING LIU.BIOSTAR PHARMACEUTICALS SAYS RONGHUA WANG AGREED TO SELL HIS 426,999 SHARES OF CO IN PRIVATE SALE TO WAIPING LIU AT $1.57/SHARE.  Full Article

Waiping Liu Says Plans To Nominate New Chairman At Biostar Pharmaceuticals
Monday, 2 Jul 2018 

July 2 (Reuters) - Biostar Pharmaceuticals Inc ::WAIPING LIU SAYS PLANS TO NOMINATE NEW CHAIRMAN AT BIOSTAR PHARMACEUTICALS - SEC FILING.WAIPING LIU REPORTS 16.2% STAKE IN BIOSTAR PHARMACEUTICALS INC AS OF JUNE 4.WAIPING LIU SAYS PLANS TO NOMINATE CERTAIN CANDIDATES FOR ELECTION TO BOARD OF BIOSTAR PHARMACEUTICALS.WAIPING LIU SAYS ALSO ANTICIPATES CONSIDERING NEW BUSINESS PLANS FOR BIOSTAR PHARMACEUTICALS GOING FORWARD.  Full Article

Biostar Pharmaceuticals Files For Non-Timely 10-Q
Wednesday, 16 May 2018 

May 16 (Reuters) - Biostar Pharmaceuticals Inc ::BIOSTAR PHARMACEUTICALS FILES FOR NON-TIMELY 10-Q WITH U.S. SEC - SEC FILING.  Full Article

Biostar Pharma qtrly ‍loss per share $0.05
Monday, 20 Nov 2017 

Nov 20 (Reuters) - Biostar Pharmaceuticals Inc ::Biostar Pharmaceuticals Inc. announces its quarterly results for nine months ended September 30, 2017.Biostar Pharmaceuticals Inc - qtrly ‍loss per share $0.05.  Full Article

Biostar Pharmaceuticals qtrly loss per share $‍0.50​
Wednesday, 15 Nov 2017 

Nov 15 (Reuters) - Biostar Pharmaceuticals Inc :Biostar Pharmaceuticals, Inc. announces its quarterly results for three months ended June 30, 2017.Biostar Pharmaceuticals Inc - ‍during fiscal Q2 of 2017 company recognized no net sales​.Biostar Pharmaceuticals Inc qtrly loss per share $‍0.50​.  Full Article

BRIEF-Biostar Pharmaceuticals Files For Non-Timely 10-Q

* BIOSTAR PHARMACEUTICALS FILES FOR NON-TIMELY 10-Q WITH U.S. SEC - SEC FILING Source http://bit.ly/2wLwd7M Further company coverage: